TROY, N.Y., June 2 -- Evident Technologies today announced it has entered into a license agreement with IBM for lead selenide (PbSe) quantum dots. This license enables Evident Technologies to make, use, offer to sell and sell PbSe nanocrystals based on IBM's production methods. As part of the agreement, Evident will provide materials produced under the agreement to IBM, and IBM will provide consulting services to Evident.
Clinton Ballinger, CEO of Evident Technologies, said, "We know that quantum dot nanocrystals offer benefits to a whole plethora of applications, ranging from lasers to lighting to photonics. These materials have been rare and hard to obtain in the past. By making these materials commercially available, a wealth of applications for quantum dots can move out of the research lab and into practical devices and products."
For more information, visit: www.evidenttech.com